Formalin fixation can produce crosslinks, fragmentation, and chemical damage in recovered DNA. These changes may reduce the quality of templates available for analysis and introduce altered bases that complicate sequence interpretation. Consequently, comparisons should incorporate DNA quality assessment and consider whether an observed difference reflects a true tumor alteration or preservation-related damage.
A matched reference provides a comparison point for separating tumor-associated changes from sequence differences unrelated to the tumor or introduced during specimen preservation. Depending on the study, the reference may come from blood, adjacent normal tissue, or another specimen. This comparison strengthens interpretation of mutation profiles and helps evaluate whether detected changes are genuine.
Interpretation depends on combining sequence comparison with information about DNA quality and specimen handling. Fragmented templates and altered bases can create misleading differences, whereas a finding supported by comparison with an appropriate reference is more informative. This distinction matters when analyzing archival tissue, where preservation effects may otherwise be confused with tumor biology.
The workflow begins by recovering DNA from the formalin-fixed, paraffin-embedded tissue, followed by assessing the quality of the extracted material. Researchers then compare sequence information from the FFPE specimen with DNA from a matched reference or another specimen. Accounting for degradation and altered bases throughout these stages supports more reliable interpretation.
Archival FFPE tissue may be compared with blood, adjacent normal tissue, or a newer biopsy, depending on the research question and available specimens. Blood or adjacent normal tissue can provide a matched comparison, while a newer biopsy allows assessment across time or specimen types. Each pairing helps place observed genetic differences in biological context.
In cancer research, the approach supports mutation profiling, examination of tumor heterogeneity, and comparison of archival samples with newer biopsies. It also enables molecular analysis of tissue collected during routine pathology or preserved in long-term studies. These applications extend genetic investigation to specimens that remain valuable even when fresh material is unavailable.